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dc34/Ubc3 is a ubiquitin-conjugating enzyme that
functions in targeting proteins for proteasome-medi-
ated degradation at the G1 to S cell cycle transition.
Elevation of Cdc34 protein levels by microinjection of bac-
terially expressed Cdc34 into mammalian cells at prophase
inhibited chromosome congression to the metaphase plate
with many chromosomes remaining near the spindle poles.
Chromosome condensation and nuclear envelope break-
down occurred normally, and chromosomes showed os-
cillatory movements along mitotic spindle microtubules.
Most injected cells arrested in a prometaphase-like state.
Kinetochores, even those of chromosomes that failed to
congress, possessed the normal trilaminar plate ultrastruc-
C
 
ture. The elevation of Cdc34 protein levels in early mito-
sis selectively blocked centromere protein E (CENP-E), a
mitotic kinesin, from associating with kinetochores. Other
 
proteins, including two CENP-E–associated proteins, BubR1
 
and phospho-p42/p44 mitogen-activated protein kinase,
and mitotic centromere-associated kinesin, cytoplasmic
dynein, Cdc20, and Mad2, all exhibited normal localiza-
tion to kinetochores. Proteasome inhibitors did not affect
the prometaphase arrest induced by Cdc34 injection.
These studies suggest that CENP-E targeting to kinetochores
is regulated by ubiquitylation not involving proteasome-
mediated degradation.
 
Introduction
 
The expanding list of proteins to which ubiquitin is ligated
includes transcription factors, tumor suppressors, protoon-
cogenes, signal transduction receptors, and proteins involved
in development, apoptosis, and DNA repair (Jentsch, 1992;
Hochstrasser, 1996; Hershko and Ciechanover, 1998).
Ubiquitin is first activated by a ubiquitin-activating enzyme
(E1), transferred to a ubiquitin-conjugating enzyme (E2),
and then covalently attached to a target protein, which can
occur directly or may require a ubiquitin-protein ligase (E3).
Subsequent ubiquitin units are conjugated to the initial
molecule, forming a multiubiquitin chain on the target,
which is recognized by the 26S proteasome. The target is
then degraded, releasing free ubiquitin to be recycled in the
process (for review see Hershko and Ciechanover, 1998).
Although proteasome-mediated degradation is the most
thoroughly studied outcome of multiubiquitin addition to
proteins, several examples of reversible ubiquitin conjugation
as a posttranslational regulatory modification are known.
These include the attachment ubiquitin to cell surface
membrane receptors (for review see Hicke, 2001), histone
H2B (Robzyk et al., 2000), the large ribosomal subunit L28
(Spence et al., 2000), and the transcription factor Met4
(Kaiser et al., 2000). In addition, the conjugation of ubiq-
uitin-like proteins such as SUMO/SMT3 can serve as
modifiers in protein localization (Matunis et al., 1998),
centromere function (Jiang and Koltin, 1996), or disjunc-
tion of homologues in meiosis (Apionishev et al., 2001).
The E2 Cdc34 (Ubc3) was identified by Goebl et al.
(1988) as a ubiquitin-conjugating enzyme in budding yeast.
The human homologue of Cdc34 was discovered by its abil-
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ity to suppress budding yeast 
 
mec1, 
 
a DNA damage check-
point mutation, and human Cdc34 is able to complement a
 
cdc34-2
 
 temperature-sensitive strain (Plon et al., 1993). All
E2 enzymes, including Cdc34, contain a ubiquitin-conju-
gating domain of 
 
 
 
16 kD, which includes the essential cys-
teine residue for thiolester formation with ubiquitin. Muta-
tion of the catalytic cysteine to alanine destroys any ability of
Cdc34 to form a bond with ubiquitin (Sung et al., 1990;
Banerjee et al., 1995).
In yeast, 
 
Xenopus
 
, and mammals, Cdc34 participates in a
ubiquitylation pathway that involves an E3 termed the
Skp1-Cdc53/cullin–F-box protein (SCF)* complex (for re-
view see Deshaies, 1999). In budding yeast, one target of
Cdc34/SCF activity is Sic1p, an inhibitor of Clb/Cdc28
that must be degraded for entry into S phase (Schwob et al.,
1994; Feldman et al., 1997). Cdc34 also participates in the
G1/S transition of animal cells, targeting the mammalian cy-
clin-dependent kinase inhibitor p27 for proteolysis (Pagano
Figure 1. Injection of Cdc34 protein into prophase 
cells causes prometaphase arrest, and injection into 
prometaphase cells causes a delay at metaphase. Phase–
contrast images of injected Ptk1 cells. (A) Buffer was 
injected into the cytoplasm of this cell during prophase. 
The nuclear envelope broke down within 2 min of injec-
tion, and chromosomes aligned  20 min later. The cell 
spent  8 min at metaphase and is shown  2 min after 
anaphase onset. (B) Recombinant Cdc34CA (a catalyti-
cally inactive form of Cdc34 protein) was injected into 
the cytoplasm of this cell during prophase. Progression 
through mitosis occurred with timing similar to the cell in 
A. (C and D) Injection of wild-type Cdc34 into cells at 
prophase. Both cells were injected in the cytoplasm just 
before capture of the first images. Nuclear envelope 
breakdown occurred normally in each cell. Many of the 
chromosomes of cells shown in B and C remained 
monooriented and never aligned at the metaphase plate 
during the 1-h observation period. (E) The prometaphase 
cell was injected with Cdc34CA protein immediately be-
fore the 0-min image was acquired. Chromosomes 
aligned, and the cell spent  10 min at metaphase then 
initiated anaphase. (F) The prometaphase cell was 
injected immediately before the first image was taken. Af-
ter  40 min at metaphase, anaphase began. The cell is 
shown  3 min after anaphase onset. Bar, 5  m.
 
*Abbreviations used in this paper: CENP-E, centromere protein E; Emi,
early mitotic inhibitor; MCAK, mitotic centromere-associated kinesin;
SCF, skp1-Cdc53/cullin–F-box protein. 
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et al., 1995; Carrano et al., 1999; Sutterluty et al., 1999)
and the 
 
Xenopus 
 
homologue Xic1 (Yew and Kirschner,
1997).
Many other proteins are degraded in a Cdc34-dependent
manner, including Far1 (Henchoz et al., 1997), CDC6
(Drury et al., 1997), Gcn4 (Kornitzer et al., 1994), Gic2
(Jaquenoud et al., 1998), G1 cyclins (Deshaies et al., 1995;
Yaglom et al., 1995; Willems et al., 1996), and HO endonu-
clease (Kaplun et al., 2000) in budding yeast, and inducible
cAMP early repressor (ICERII
 
 
 
), activating transcription
factor 5 (Pati et al., 1999), transcription factors Myo D
(Song et al., 1998) and E2F-1 (Marti et al., 1999), and the
transcriptional regulator B-Myb (Charrasse et al., 2000) in
mammals.
Evidence also links Cdc34 to the G2/M phase of the cell
cycle. Cdc34 is involved in the degradation of the budding
yeast Cdk inhibitory kinase Swe1 (Kaiser et al., 1998) and
the 
 
Xenopus
 
 homologue Wee1 (Michael and Newport,
1998). Both act to inhibit entry into mitosis (Mueller et al.,
1995; Murakami and Vande Woude, 1998). Previous stud-
ies suggest that Cdc34 also plays an important role in the
function of the budding yeast kinetochore complex called
CBF3. One component of the complex, Ctf13p, is degraded
through the Cdc34 pathway (Kaplan et al., 1997). In addi-
tion, overexpression of Cdc34 suppresses the growth defect
in one mutant allele of another component called Ndc10p
(Yoon and Carbon, 1995). In mammalian cells, Cdc34 was
reported to associate with the mitotic spindle in anaphase,
 
Table I. 
 
Progression of microinfected cells through mitosis
Injection
Cell phase
at injection
Number of cells
injected
Number of cells
arrested at prometaphase
Number of cells
arrested at metaphase
Number of cells
that completed mitosis
 
Buffer Prophase 8 8
Prometaphase 2 2
Cdc34CA (
 
 
 
3 mg/mL) Prophase 11 11
Prometaphase 4 4
Cdc34CA (
 
 
 
3 mg/mL) Prophase 104 89 5 10
Prometaphase 24 18 5 1
Late prometaphase 11 4 7*
Anaphase 6 6
Cdc34 (3 mg/mL) denatured Prophase 6 6
Prometaphase 3 3
Cdc34 (1.5 mg/mL) Prophase 11 7 4
Cdc34 (3 mg/mL) with
10 
 
 
 
m MG132 or 
 
 
 
-lactone Prophase 15 15
*These cells spent on average 32.5 min at metaphase, which is significantly different from uninjected cells (
 
P
 
 
 
 
 
 0.05).
Figure 2. Chromosome oscillation during Cdc34 induced prometaphase arrest. (A) Ptk1 cell injected with Cdc34 protein at prophase. The 
spindle poles were widely separated at the time of nuclear envelope breakdown, and all of the chromosomes assumed an initial monopolar 
orientation. A curved arrow indicates the lower pole. The straight white line is drawn an equal distance from the pole in all panels to serve as 
a position reference. The chromosome indicated by the white arrow begins at the white line and then moves repeatedly away from and 
toward the lower pole during the observation period. In contrast, the chromosomes indicated by the white arrowhead in the first and last 
images undergo very little motion relative to the spindle pole. Time is indicated in minutes and seconds. A Quicktime video of the time-lapse 
phase image referring to Fig. 2 (Video 1) and additional examples of chromosome behavior in cells injected with Cdc34 protein (videos 2 and 
3) are available at http://www.jcb.org/content/vol154/issue4/707. Bar, 10  m. 
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suggesting that it may play a role in events of late mitosis
(Reymond et al., 2000).
In higher eukaryotes, the mitotic spindle microtubules at-
tach to the kinetochores after nuclear envelope breakdown,
and each chromosome moves individually to align at the
metaphase plate. The mechanism regulating this alignment
is unknown. We found that microinjection of recombinant
human Cdc34 into cells inhibits chromosome movement to
the metaphase plate (Bastians et al., 1999). Here, we exam-
ine this effect in more detail in rat kangaroo Ptk1 and por-
cine LLC-Pk cells. Microinjection of wild-type Cdc34 but
not an inactive Cdc34 mutant into mammalian cells in early
mitosis caused an arrest at prometaphase. Typical bipolar
spindles formed in arrested cells. The ultrastructure of kinet-
ochores and attachment of microtubules to kinetochores ap-
peared normal. However, localization of the kinesin motor,
centromere protein E (CENP-E), to mitotic kinetochores
was inhibited in cells injected with wild-type Cdc34. The lo-
calization of other kinetochore proteins, including other
motor proteins, was unaffected. Our results indicate that
overexpression of Cdc34 specifically blocks CENP-E associ-
ation with kinetochores and disrupts events of early chromo-
some movement in mitosis.
 
Results
 
Microinjection of wild-type Cdc34 protein arrests Ptk1 
cells in prometaphase
 
In a previous study, we found unexpectedly that microinjec-
tion of Cdc34 into mammalian cells caused inhibition or de-
lay of chromosome alignment at the metaphase plate (Bas-
tians et al., 1999). Although initially reported to be a
consequence of injection with the cys
 
93
 
→
 
ser
 
93
 
–leu
 
97
 
→
 
ser
 
97
 
mutant, resequencing of the constructs from which the bac-
terially expressed proteins were prepared revealed that these
original results were obtained after injection of wild-type
Cdc34. Subsequently, we reanalyzed the effect in mitosis
and compared chromosome behavior in Ptk1 cells injected
with wild-type Cdc34 or inactive mutant Cdc34 protein
in which the catalytic cysteine was replaced with alanine,
Cdc34CA. Budding yeast Cdc34 protein harboring this
same mutation is devoid of any ubiquitin-conjugating activ-
ity (Banerjee et al., 1995).
 
Mitotic progression of injected cells is shown in Fig. 1 and
Table I. Cells injected during prophase with buffer required
on average 
 
 
 
30 min to reach metaphase after chromosomes
achieved bipolar attachment. Initiation of anaphase began
 
 
 
14 min after metaphase, and cytokinesis was completed
 
 
 
20 min later. Cells injected in the cytoplasm at prophase
with the inactive Cdc34CA protein progressed through mi-
tosis at rates similar to buffer-injected cells (Fig. 1 B). In
contrast, cells injected in the cytoplasm during prophase
with wild-type Cdc34 arrested at prometaphase (Fig. 1, C
and D). The level of Cdc34 protein expression does not ap-
pear to vary with cell cycle (Goebl et al., 1988; Reymond et
al., 2000). By quantifying immunoblots and comparing a
known amount of recombinant Cdc34 with extracts pre-
pared from a known number of cells, we estimate that an
individual Ptk1 cell contains 
 
 
 
0.2 picograms of Cdc34
protein. Thus, the minimum amount of injected Cdc34
necessary to observe effects on chromosome movement was
approximately five times the endogenous level. In cells in-
jected with Cdc34, the chromosomes attached to microtu-
bules of the mitotic spindle and oriented toward the poles
after nuclear envelope breakdown. In most cells observed af-
ter injection of Cdc34, some chromosomes showed typical
prometaphase chromosome oscillations (Fig. 2). However,
other chromosomes showed little movement, and many
never aligned at the metaphase plate during the observation
period. A few cells that were injected with wild-type Cdc34
in the early stages of mitosis did successfully align their chro-
mosomes at the metaphase plate and arrested at metaphase
(Table I). 12 of the cells injected at prophase with Cdc34 (
 
 
 
3 mg/mL) included in Table I were followed for 2–6 h be-
yond nuclear envelope breakdown. 11 remained arrested in
a prometaphase-like state, and 1 arrested at metaphase. In-
jection during late prometaphase usually delayed the onset
of anaphase (Table I and Fig. 1 F). Injection of Cdc34 pro-
tein after anaphase onset did not impair completion of mito-
sis or cytokinesis (Table I). The prometaphase arrest was also
observed when LLC-Pk cells in prophase were injected with
Cdc34 (unpublished data).
 
Normal prometaphase characteristics are observed in 
the presence of high levels of Cdc34
 
Spindles that formed in the Cdc34-injected cells were bipo-
lar and contained astral, kinetochore, and nonkinetochore
spindle microtubules (Fig. 3 A). This morphology resem-
bled that of uninjected cells fixed in prometaphase. Ultra-
structurally, kinetochores in cells injected with Cdc34 ap-
peared identical to kinetochores of uninjected cells (Fig. 3
B). In injected cells, some chromosomes were found situ-
ated unusually close to the centriole at the spindle pole (Fig.
3
 
 
 
B, c, arrowhead). However, sister kinetochores (Fig. 3
 
 
 
B
 
,
 
c, white arrows) of chromosomes situated between the spin-
dle poles (Fig. 3 B, c, black arrows) were widely separated,
indicating the kinetochore area was under bipolar tension.
We quantified the distances between sister kinetochores of
chromosomes at the midplane and near the spindle poles in
Cdc34-injected and uninjected cells (Table II). For both
bioriented or monooriented chromosomes, we found no
significant differences in the interkinetochore distances,
comparing injected and uninjected cells. Nocodazole treat-
 
Table II. 
 
Interkinetochore distances
Uninjected Cdc34-injected
 
Chromosomes at midplane
Average 
 
 
 
m 
 
 
 
 SD 1.73 
 
 
 
 0.38 1.68 
 
 
 
 0.28
Range 1.11–2.59 1.36–2.33
Sister kinetochores/cells 24/10 21/12
Chromosomes at poles
Average 
 
 
 
m 
 
 
 
 SD 1.22 
 
 
 
 0.19 1.35 
 
  
 
0.28
Range 0.9–1.59 0.7–1.86
Sister kinetochores/cells 15/8 15/7
Nocodazole-treated
Average 
 
 
 
m 
 
 
 
 SD 1.08 
 
 
 
 0.21* 1.23 
 
 
 
 0.17*
Range 0.66–1.35 0.85–1.59
Sister kinetochores/cells 18/4 26/4
*Values are significantly different from the average interkinetochore dis-
tance of sister kinetochores at midplane and near the spindle poles of cells
that were not exposed to nocodazole (
 
P
 
 
 
  
 
0.05). 
Cdc34 inhibits metaphase alignment of chromosomes |
 
 Topper et al. 711
 
Injection of Cdc34 causes mislocalization of CENP-E in 
mitotic cells
 
Inhibition of CENP-E function in mammalian cells by anti-
body microinjection or introduction of antisense constructs
prevents congression of chromosomes to the metaphase
plate (Schaar et al., 1997; Yao et al., 2000). Similar results
are obtained by immunodepletion of CENP-E from 
 
Xenopus
 
egg extracts (Wood et al., 1997). Because the chromosomes
in cells injected with wild-type Cdc34 protein also fail to
achieve metaphase alignment, we assessed the distribution of
CENP-E in injected cells. In Fig. 4, C and D, injection of
Cdc34 into Ptk1 cells inhibited CENP-E localization at ki-
ment reduced the interkinetochore distances of both in-
jected and noninjected cells similarly (Table II.). These re-
sults suggest that the excess Cdc34 protein did not interfere
with kinetochore attachment to microtubules or spindle as-
sembly or cause structural alterations in the centromeric
chromatin between sister kinetochores. Cells injected with
Cdc34 protein were stably arrested in M phase as deter-
mined by several markers of M phase arrest including ex-
pression of phosphorylated histone H3 (Hendzel et al.,
1997) and dispersed distribution of nuclear pore antigens
(Snow et al., 1987) (Fig. S1 available at http://www.jcb.org/
content/vol154/issue4/707).
Figure 3. Bipolar spindles and normal kineto-
chores form in cells injected with Cdc34. (A) 
Cells were injected with Cdc34 protein, 
observed to undergo nuclear envelope break-
down, and were further observed for  45 min 
before fixation. Both fixed cells were labeled 
with antitubulin (red) and anticentromere 
(green) antibodies. (B) Ultrastructure of kineto-
chores in injected cells. The chromosome 
distribution of an uninjected prometaphase cell 
is shown (a) with an enlargement of a kineto-
chore from that cell (b). The inner and outer 
plates of the trilaminar structure are denoted (b, 
arrows). The chromosome distribution of a cell 
injected with Cdc34 (c) appears similar to the 
pattern in the uninjected cell. However, as 
often seen in Cdc34-injected cells a chromo-
some is situated very close to the spindle pole 
(arrowhead). Kinetochores of the injected cell 
(d) show a clear trilaminar structure with micro-
tubules embedded in the outer plate. Bars: (A 
and B, a) 10  m; (B, b) 2  m. 
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Figure 4.
 
CENP-E is mislocalized in Cdc34-injected cells.
 
 (A) The association of CENP-E (red) with kinetochores of an uninjected cell. The 
kinetochores (green, closed arrows) appear yellow as a result of colocalization of anti-CENP-E and antikinetochore antibodies. (B) Injection of 
Cdc34CA did not affect CENP-E localization to sister kinetochores (B, closed arrows). (C and D) Cells were injected in prophase with Cdc34 
protein. Both were incubated for 
 
 
 
45 min after nuclear envelope breakdown was detected. Immunolabeling reveals that CENP-E is localized  
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netochores and caused CENP-E protein (red) to accumulate
in irregular aggregates in the cytoplasm that did not colocal-
ize with the kinetochores (green). Injection of the Cdc34CA
enzymatically inactive mutant did not affect localization of
CENP-E to kinetochores (Fig. 4 B). Mislocalization of
CENP-E was not a property unique to Ptk1 cells, since in-
jected LLC-Pk cells show similar displacement of CENP-E
from the kinetochores into cytoplasmic aggregates (Fig. 4 F).
Displacement of CENP-E by Cdc34 was specific for CENP-E.
Mitotic centromere-associated kinesin (MCAK), another
member of the kinesin superfamily (Wordeman and Mitchi-
son, 1995; Walczak et al., 1996; Maney et al., 1998), and
dynein, a minus end–directed motor protein that also local-
izes to kinetochores (Pfarr et al., 1990; Steuer et al., 1990)
were not altered by microinjection of Cdc34 (Fig. 5, B
and D).
 
Mitotic spindle localization of proteins other than 
CENP-E are not affected by injection of Cdc34
 
Certain kinases, namely the mitotic checkpoint kinase
BubR1 and active Erk1/2 (extracellular signal regulated ki-
nases 1 and 2 also called p42/p44 mitogen-activated protein
kinase) localize to kinetochores during prometaphase and
have been associated with CENP-E (Cahill et al., 1998;
Zecevic et al., 1998; Chan et al., 1999). Other mitotic
checkpoint proteins including Cdc20/p55CDC and Mad 2
that localize to kinetochores during M phase (Li and Ben-
ezra, 1996;
 
 
 
Kallio et al., 1998) were unaffected by injection
of Cdc34 (Fig. S2 available at http://www.jcb.org/content/
vol154/issue4/707). In budding yeast, Cul1/Cdc53 associ-
ates with Cdc34 in all phases of the cell cycle (Mathias et al.,
1998). In Ptk1 cells, we found that Cul1 is concentrated at
centrosomes during mitosis. Injection of Cdc34 protein did
not appear to affect the subcellular localization of any of
these proteins in mitotic cells (Figs. S1 and S2 available at
http://www.jcb.org/content/vol154/issue4/707). Finally, one
trivial reason Cdc34 might affect cellular processes is simply
by sequestering free ubiquitin. However, coinjection of a
large molar excess of ubiquitin did not reverse the Cdc34-
induced prometaphase arrest (unpublished data).
 
Proteasome inhibitors do not affect prometaphase 
chromosome movements or CENP-E localization to 
kinetochores; the effect of Cdc34 on chromosome 
movement is independent of proteasome activity
 
The injection of Cdc34 protein might affect the degradation
of proteins during prometaphase, either causing an unsched-
uled degradation or inhibiting a required degradation. Most
previous studies with rodent and HeLa cells have shown that
proteasome inhibition blocks anaphase onset but does not
affect chromosome alignment at the metaphase plate (Sher-
wood et al., 1993; Wojcik et al., 1996). Similarly, we found
that treatment of Ptk1 and LLC-Pk cells with proteasome
inhibitors MG132 or 
 
 
 
-lactone–induced metaphase arrest
without impairment of chromosome movement in pro-
metaphase (Fig. 6 A).
If the Cdc34 injection displaces CENP-E simply because
it interferes with a required degradation, then loss of CENP-E
at kinetochores and formation of cytoplasmic aggregates of
CENP-E should also occur in cells exposed to proteasome
inhibitors. However, we found that proteasome inhibition
with MG132 (Fig. 6 A) or 
 
 
 
-lactone (unpublished data) did
 
to distinct cytoplasmic aggregates (open arrows) but not on kinetochores (closed arrows). In some instances, yellow kinetochores in the 
merged image result from the aggregates of CENP-E being in close proximity to kinetochores rather than a true colocalization of anti–CENP-E 
and antikinetochore antibodies. (E and F) Insets show enlargements of the boxed regions of each cell and illustrate that CENP-E (red) is found 
on kinetochores (green) of an uninjected prometaphase LLC-Pk cell (E). CENP-E does not concentrate at kinetochores in the Cdc34-injected 
LLC-Pk cell (F). Each image of a cell was taken at the same focal plane. Bars, 10 
 
 
 
m.
Figure 5. Cdc34 does not affect localization of MCAK and dynein 
to kinetochores. (A and B) The cell in A arrested at prometaphase 
after injection with Cdc34. Pairs of kinetochores in the Cdc34-
injected and control cell and the corresponding MCAK localization 
(arrows) are indicated. (C and D) The cells were exposed to nocoda-
zole for 30 min. Cdc34 protein was injected into the cell in C and 
was incubated for  45 min after nuclear envelope breakdown in 
the presence of the drug. Dynein association with kinetochore pairs 
(arrows) appears similar in the Cdc34-injected cell (C) and a neigh-
boring uninjected cell (D). The two images for each cell were taken 
in the same focal plane. Bars, 10  m. 
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not affect CENP-E localization to kinetochores (Fig. 6 B,
yellow kinetochores), and thus the effect of Cdc34 on
CENP-E in prometaphase is not likely mediated by inhib-
ited proteolysis.
To determine whether Cdc34 induced unscheduled de-
struction of a normally stable protein in prometaphase, cells
were treated with proteasome inhibitors 20–40 min before
injection of Cdc34 protein. Prophase cells injected with
Cdc34 protein while in medium containing MG132 or 
 
 
 
-lac-
tone completed nuclear envelope breakdown and arrested in
prometaphase (Table I), similar to injected cells that were
not incubated with proteasome inhibitor. Thus, inhibition
of proteasome activity failed to rescue the injected cells from
the prometaphase arrest induced by Cdc34.
 
Discussion
 
Cdc34 activity and CENP-E
 
Here, we show that injection of excess Cdc34 into mamma-
lian cells selectively blocks the normal association of CENP-E
with kinetochores and inhibits chromosome alignment at
metaphase. We found that some chromosomes continued to
undergo oscillatory movements in cells injected with Cdc34.
However, monooriented chromosomes situated very near
the poles underwent fewer apparent movements. In cells in-
jected with Cdc34, many chromosomes near the spindle
midplane exhibited normal bipolar connections. However,
we detected monooriented chromosomes abnormally close
to the spindle poles. We speculate that the physiological role
of Cdc34 and/or CENP-E may be to rescue mono-oriented
chromosomes near the poles by facilitating bipolar attach-
ment of the distal kinetochores of monooriented chromo-
somes or by providing antipoleward directed forces.
CENP-E was identified as a kinetochore-associated pro-
tein by Yen et al. (1991) and as a plus end–directed motor
by Wood et al. (1997). Direct interference with CENP-E
function in 
 
Xenopus
 
 extracts or in mammalian cells inhibits
chromosome alignment at metaphase (Schaar et al., 1997;
Wood et al., 1997). Antisense inhibition of CENP-E levels
in mammalian cells also results in a prometaphase arrest
(Yao et al., 2000). The antisense treatment also induced a
loss of tension between sister kinetochores, which did not
occur upon injection of Cdc34 protein (Table II). Possibly
antisense techniques may deplete CENP-E earlier or more
thoroughly than does injection of Cdc34 protein.
As yet, we cannot determine whether the effect of micro-
injected Cdc34 on CENP-E localization is direct or indirect.
Microinjection of a commercial anti-Cdc34 antibody had
no apparent effects, but we do not know if this antibody in-
hibits Cdc34 activity in vivo (unpublished data). We have
not detected coimmunoprecipitation of Cdc34 and CENP-E
in cellular extracts. Also, immunolabeling of Cdc34-injected
cells with anti-Cdc34 antibody did not reveal aggregates of
Cdc34 protein in the cytoplasm as we had observed for
CENP-E. Injected Cdc34 protein was distributed through-
out the entire cell in a speckle pattern that is similar to previ-
ous findings (Reymond et al., 2000). In late mitosis, near
the transition to G1, CENP-E levels fall, and proteasome in-
hibitors can block this decrease (Brown et al., 1994). If in-
jection of Cdc34 resulted in premature degradation of
CENP-E, we would expect to find low levels of CENP-E in
the injected arrested cells. This did not appear to be the case.
The idea that degradation is not involved in the mislocaliza-
tion of CENP-E is supported by the observation that chemi-
cal inhibitors of proteasome function did not affect CENP-E
association with kinetochores (Fig. 6). Although den Elzen
Figure 6. Proteasome inhibition does not prevent chromosome congression or CENP-E association with kinetochores but arrests cells at 
metaphase. (A) Live images of a Ptk1 cell incubated in MG132. The cell began chromosome condensation (0 min) after 30-min incubation in 
MG132. Nuclear envelope breakdown and alignment of chromosomes at the metaphase plate occurred normally. The cell arrested at 
metaphase as shown in the 50-min image. (B) Cell was detergent extracted and fixed after incubation in MG132 for  1 h. Immunolabeling 
with anti-kinetochore antibody (green) is followed by anti–CENP-E labeling (red) taken at the same focal plane. The yellow kinetochores 
represent colocalization of the two antibodies (closed arrows). 
Cdc34 inhibits metaphase alignment of chromosomes |
 
 Topper et al. 715
 
and Pines (2001) reported recently that proteasome inhibi-
tors block prometaphase chromosome congression, we (Fig.
6 A) and others (Sherwood et al., 1993; Wojcik et al., 1996)
have found that mammalian cells treated with proteasome
inhibitors arrest at metaphase with congressed chromo-
somes. Reversible addition of ubiquitin to proteins without
proteasome degradation plays an important role as a regula-
tory posttranslational modification (Kaiser et al., 2000;
Spence et al., 2000). We speculate that ligation or removal
of ubiquitin on CENP-E or on associated proteins may serve
to regulate chromosome congression.
 
Regulation of Cdc34 and the SCF during the cell cycle
 
SCF targeting of certain proteins occurs in all phases of the
cell cycle (Galan and Peter, 1999). Cdc34 also associates
with the cullin component of the SCF, Cdc53/Cul1, during
the entire cell cycle (Mathias et al., 1998). In vertebrate cells,
Cdc34 and the SCF components are required for cen-
trosome duplication and localize to centrosomes (Freed et
al., 1999). Injection of excess Cdc34 protein did not inter-
fere with localization of the SCF component Cul1 to mitotic
centrosomes (Fig. S1 available at http://www.jcb.org/content/
vol154/issue4/707).
The intracellular level of Cdc34 in yeast and in mamma-
lian cells does not vary during the cell cycle (Goebl et al.,
1988; Reymond et al., 2000). Although expressed at all
stages, Cdc34 activity may be restricted by inhibitory mech-
anisms in early M phase. Possibly microinjection of excess
Cdc34 overwhelms this regulation, leading to the untimely
ubiquitylation of some target protein(s). An important next
step will be identification of the mitotic target(s) of Cdc34
activity. Recently, Reimann et al. (2001) identified a verte-
brate Skp1-interacting protein called early mitotic inhibitor
(Emi)-1. Emi1 functions as an inhibitor of the anaphase-
promoting complex/cyclosome, and overexpression of Emi1
induces a prometaphase arrest. Degradation of Emi1 occurs
early in mitosis but is independent of anaphase-promoting
complex/cyclosome activity. Degradation of Emi1 may re-
quire SCF activity.
Our search into the mitotic function of ubiquitin-conju-
gating enzymes revealed an unexpected effect of microin-
jecting excess wild-type Cdc34 in early mitosis: impairment
of chromosome movement and arrest at prometaphase by
the displacement of CENP-E from its normal association
with kinetochores. This evidence suggests that Cdc34 may
play a role in chromosome congression. Alternatively, it is
possible that the introduction of excess Cdc34 protein into
mitotic cells evokes a pathway normally suppressed during
M phase. These experiments point to new roles for protein
ubiquitylation in regulating chromosome movement in
early mitosis.
 
Materials and methods
 
Cell culture
 
Ptk1 cells were cultured in MEM (Life Technologies) supplemented with
10% FBS, 20 mM Hepes buffer, 1
 
 
 
 nonessential amino acids, 1 mM so-
dium pyruvate, 60 
 
 
 
g/ml penicillin, and 100 
 
 
 
g/ml streptomycin at 37
 
 
 
C
under 5% CO
 
2
 
. LLC-Pk cells were cultured under identical conditions with
the same supplements in DME (Life Technologies). Proteasome inhibitors
MG132 and clasto-lactacystin-
 
 
 
-lactone (Calbiochem) were used in cul-
ture medium at 10 
 
 
 
M.
 
Gel electrophoresis and immunoblotting
 
Recombinant wild-type and mutant Cdc34 proteins were expressed in bac-
teria and purified as reported previously in Bastians et al. (1999). Purified
recombinant proteins and Ptk1 cell extract proteins were separated by
SDS-PAGE. Proteins were transferred to Immobilon-P membrane (Milli-
pore). The membrane was blocked in 5% milk TBST (10 mM Tris, 150 mM
NaCl, 0.059, Tween-20) for 30 min followed by incubation in anti-Cdc34
monoclonal antibody (Transduction Laboratories) at a dilution of 1:1,000
into TBST followed by anti-mouse HRP-conjugated (Jackson ImmunoRe-
search Laboratories) and visualized using chemiluminescence (Dupont-
NEN Life Science Products). Characterization of the protein is shown in
Fig. S3 (available at http://www.jcb.org/content/vol154/issue4/707).
 
Microinjection
 
Microinjection chambers were prepared by cutting an 18-mm hole into
the bottom of a 60-mm plastic tissue culture dish. A 22-mm coverslip was
sealed to the inside of the dish with silicone grease. Chambers were steril-
ized by inversion on a UV transilluminator (UVP Inc.) for 15 min. Ptk1
cells were cultured on inscribed glass coverslips or Bellco gridded cover-
slips for 2–3 d to 60% confluency, and transferred to a sterile chamber
containing 4 mL of medium. The medium in the chamber was overlaid
with light mineral oil before microinjection. The chamber was placed on a
prewarmed temperature-controlled stage (Fryer Co. Inc.) at 34–36
 
 
 
C on a
Diaphot microscope (Nikon). Microinjections were performed as de-
scribed by Gorbsky et al. (1998). Cells were injected with wild-type Cdc34
(1.5–7 mg/ml), mutant Cdc34 (3–6 mg/ml), or buffer (50 mM Hepes-
NaOH, ph 7.4, 5 mM KCl, 1.5 mM MgCl
 
2
 
, 1 mM DTT) to no more than
5% of their total volume. Images were collected with a digital cooled CCD
camera (Photometrics) controlled with Metamorph software (Universal Im-
aging Corp.). Prophase cells were injected in the cytoplasm, whereas
prometaphase or anaphase cells were injected away from the chromo-
somes to avoid any damage to DNA.
 
Electron microscopy
 
Cells grown on gridded coverslips were injected and followed in vivo,
then carefully removed from the microinjection chamber, rinsed twice
with PBS warmed to 37
 
 
 
C, and fixed 40 min with 3% glutaraldehyde (Elec-
tron Microscopy Sciences) in 0.1 M PO
 
4
 
 buffer, pH 6.9, that was also
warmed to 37
 
 
 
C. Coverslips were postfixed in 2% osmium tetroxide and
dehydrated. Injected cells were located and embedded in Epon 812 by in-
verting a Beem capsule over the appropriate area. After polymerization of
the epon, the capsule was separated from the coverslip by alternate im-
mersion into hot water and liquid nitrogen. Injected cells were relocated
and the block trimmed to ensure that the only mitotic cells remaining on
the block face had been injected. Each injected cell was sectioned and
stained with uranyl acetate and lead citrate. Sections were examined in a
Jeol 100CX electron microscope at 80 kV. Micrographs were scanned into
Adobe Photoshop
 
®
 
 5.5, and final images were annotated in Microsoft
PowerPoint 2000.
Immunofluorescence
Each coverslip was rinsed at room temperature with 60 mM Pipes, 25 mM
Hepes, pH 6.9, 10 mM EGTA, 4 mM MgSO4 (PHEM). For CENP-E, dynein,
and Cul1 immunolabeling, cells were lysed with 0.5% CHAPS detergent
or 0.5% Triton X-100 in PHEM for 3 min and fixed for 15 min at room tem-
perature with 1% freshly prepared formaldehyde in PHEM. Cells labeled
with MCAK antibody were fixed for 20 min in 4% formaldehyde and then
extracted in 0.5% CHAPS in PHEM. Cells labeled with antiphospho his-
tone H3 antibody were fixed in 4% paraformaldehyde and extracted with
0.5% Triton X-100 prepared in PBS. For labeling of nuclear pore proteins
with the RL-1 antibody, cells were fixed in 1% paraformaldehyde and ex-
tracted in 0.5% CHAPS in PHEM buffer. For tubulin labeling, cells were
fixed in methanol at  20 C for 10 min. Cells were then rinsed three times
with 10 mM MOPS, pH 7.2, 150 mM NaCl containing 0.05% Tween 20
(MBST) and blocked in 20% boiled normal goat serum in MBST. Cells
were labeled with primary antibody diluted in 5% boiled normal goat se-
rum for 45 min at room temperature. The following antibodies were used
at the indicated dilutions: antitubulin ascites fluid (Dr. T. Frankfurter, Uni-
versity of Virginia) at 1:100, affinity purified rabbit anti–CENP-E antibody
and anti-BubR1 (Dr. T. Yen, Fox Chase Cancer Center, Philadelphia, PA) at
1:500, purified MCAK polyclonal antibody (Dr. L. Wordeman, University
of Washington School of Medicine, Seattle, WA) at 1:1,000, affinity puri-
fied antidynein antibody (Dr. K. Pfister, University of Virginia) at 1:500, an-
tiserum to phosphorylated histone H3 (Dr. D. Allis, University of Virginia)
at 1:5,000, RL-1 antinucleoporin monoclonal antibody (Dr. B. Paschal,
University of Virginia) at 1:100, affinity purified anti-Cul1 antibody (Labvi-
sion/Neomarkers) at 1:200, affinity purified antiphospho p42/p44 mitogen-716 The Journal of Cell Biology | Volume 154, 2001
activated protein kinase antibody (Dr. M. Weber, University of Virginia) at
8.5  g/ml, anti-p55CDC antibody (Santa Cruz Biotechnology) at 1:200,
and rabbit anti-Mad2 antibody (Dr. E. Salmon, University of North Caro-
lina, Chapel Hill, NC) at 4  g/ml. In some cases, kinetochores of cells
were colabeled with human nuclear (ANA) centromere serum (Cortex Bio-
chem, Inc.) at a 1:500 dilution. Cells were washed for 15 min in three
changes of MBST. Fluorescent secondary antibodies (Jackson ImmunoRe-
search Laboratories) were diluted in 5% boiled normal goat serum and ap-
plied at 1:400–1:2,000 for 45 min at room temperature. Coverslips were
washed and then rinsed in DAPI at 0.1  g/ml for 1 min. After rinsing twice
in distilled water, coverslips were mounted in 10  l Prolong (Molecular
Probes).
Digital images of cells were obtained with either the Diaphot micro-
scope or with a ZEISS Axioplan II equipped with a digital CCD Orca cam-
era (C4742-45; Hamamatsu) controlled by a computer using Openlab soft-
ware (Improvision, Inc.). Interkinetochore distances were measured from
the center of one sister kinetochore to the center of the other sister using
the measure distance functions in either Openlab or Metamorph software
packages.
Online supplemental material
Supplemental Figs. 1–3 and videos 1–3, complementing the images pre-
sented in the print version of this article, are available online at http://
www.jcb.org/content/vol154/issue4/707.
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